Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration

International Journal of Oncology

Volumn 28, Issue 5, 2006, Pages 1081-1088

  Zhao, Wei ^a   Liu, Haiyan ^b   Liu, Wei ^a   Wu, Yinwei ^a   Chen, Wei ^b   Jiang, Bin ^c   Zhou, Yue ^b   Xue, Rong ^a   Luo, Chan ^a   Wang, Lan ^a   Jiang, Jian Dong ^d   Liu, Jingwen ^b  

^a Nanjing Second Hospital   (China)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

DNA methylation; Liver cancer; Liver cirrhosis; Metastasis; Synuclein gamma

Indexed keywords

AZACITIDINE; GAMMA SYNUCLEIN; SNCG PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER STAGING; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ADULT; AZACITIDINE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING;

EID: 33646841848     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.5.1081     Document Type: Article

References (34)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Tischoff I, Markwarth A, Witzigmann H, et al: Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 115: 684-689, 2005.
3. Thomas MB and Zhu AX: Hepatocellular carcinoma: the need for progress. J Clin Oncol 23: 2892-2899, 2005.
4. Borlak J, Meier T, Halter R, Spanel R and Spanel-Borowski K: Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumors. Oncogene 24: 1809-1819, 2005.
5. Fausto N: Growth factors in liver development, regeneration and carcinogenesis. Prog Growth Factor Res 3: 219-234, 1991.
6. Ito Y, Takeda T, Sakon M, et al: Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer 84: 1377-1383, 2001. (Pubitemid 32522107)
7. Masumoto A, Arao S and Otsuki M: Role of beta 1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology 29: 68-74, 1999.
8. Yamamoto H, Itoh F, Sakamoto H, et al: Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma. Int J Cancer 74: 251-254, 1997. (Pubitemid 27321791)
9. Mckillop IH, Schmidt CM, Cahill PA, et al: Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocarcinoma. Hepatology 26: 1484-1491, 1997.
10. Kazachkov Y, Khaoustov V, Yoffe B, et al: p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis 17: 2207-2212, 1996.
11. Liew CT, Li HM, Lo KW, et al: Frequent allelic loss on chromosome 9 in hepatocarcinoma. Int J Cancer 81: 319-324, 1999.
12. Park WS, Cho YG, Kim CJ, et al: Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 37: 276-281, 2005.
13. Zhu JD: The altered DNA methylation pattern and its implications in liver cancer. Cell Res 15: 272-280, 2005.
14. Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF and Zhu J: Methylation profiling of twenty four genes and the concordant methylation behaviors of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 13: 319-333, 2003.
15. Lavedan C, Leroy E, Dehejia A, et al: Identification, localization and characterization of the human γ-synuclein gene. Hum Genet 103: 106-112, 1998.
16. Ninkina N, Alimova-Kost M, Paterson J, et al: Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet 7: 1417-1424, 1998.
17. Ji H, Liu Y, Jia T, et al: Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57: 759-764, 1997.
18. Lu A, Gupta A, Li C, et al: Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 20: 5173-5185, 2001.
19. Liu H, Liu W, Wu YW, et al: Loss of epigenetic control of synuclein-gamma gene as a molecular indicator for metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643, 2005.
20. Gupta A, Godwin AK, Vanderveer L, et al: Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63: 664-673, 2003.
21. Bruening W, Giasson B, Klein-Szanto J, et al: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163, 2000.
22. Wu K, Weng Z, Tao Q, et al: Stage-specific expression of breast cancer-specific gene γ-synuclein. Cancer Epidemiol Biomarkers Prev 12: 920-925, 2003.
23. Liu J, Spence MJ, Zhang YL, et al: Transcriptional suppression of synuclein γ (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Res Treat 62: 99-107, 2000.
24. Lu A, Zhang F, Gupta A and Liu J: Blockade of AP1 transactivation abrogated the abnormal expression of the breast cancer specific gene 1 in breast cancer cells. J Biol Chem 277: 31364-31372, 2002.
25. Jiang Y, Liu YE, Lu A, et al: Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 63: 3899-3903, 2003.
26. Jia T, Liu Y, Liu J and Shi Y: Stimulation of breast cancer invasion and metastasis by breast cancer-specific synuclein (SNCG). Cancer Res 59: 742-747, 1999.
27. Jiang GF, Liu YA, Goldberg ID and Shi YE: γ synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor α signaling and mammary tumorigenesis. Cancer Res 64: 4539-4546, 2004.
28. Gupta A, Inaba S, Wong OK, et al: Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593-7599, 2003.
29. Pan Z, Bruening W, Giasson BI, et al: γ-Synuclein promotes cancer cell survival and inhibits stress- and chemotherapy druginduced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050-35060, 2002.
30. Inaba S, Li C, Shi YE, et al: Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94: 25-35, 2005.
31. Esteller M, Sparks A, Toyota M, et al: Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60: 4366-4371, 2000.
32. Harris AJ, Dial SL and Casciano DA: Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat Res 549: 79-99, 2004.
33. Yanagawa N, Tamura G, Honda T, et al: Demethylation of the synuclein γ gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res 10: 2447-2451, 2004.
34. Sharma RA and Farmer PB: Biological relevance of adduct detection to the chemoprevention of cancer. Clin Cancer Res 10: 4901-4912, 2004.